Not Yet RecruitingNot Applicable

Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders

Taiwan120 participantsStarted 2026-01-02

Plain-language summary

This study aims to verify the safety and preliminary clinical benefits of long-term gait training using AI-powered smart electric vehicles for patients with neurodegenerative diseases such as Parkinson's disease and dementia.

Who can participate

Age range50 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with neurodegenerative diseases (such as Parkinson's disease or dementia).
✓. Age between 50-85 years.
✓. Capable of walking for at least 10 meters, but may have unsteady gait or history of falls.
✓. Able to understand the trial procedures and give informed consent.

Exclusion criteria

✕. Severe cardiopulmonary disease or recent major surgery.
✕. Unable to walk or requiring comprehensive physical support.
✕. Severe cognitive impairment preventing understanding of the trial procedures or giving informed consent.
✕. Visual or auditory impairments severe enough to prevent following trial instructions.

What they're measuring

Gait speed

Timeframe: Before & after training (the training sessions will last for 2~12 weeks).

Trial details

NCT IDNCT07230366

SponsorTaipei Medical University Shuang Ho Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-12-10

Contact for this trial

Chien Tai Hong, MD, PhD

+886 970747668 15004@s.tmu.edu.tw

View on ClinicalTrials.gov More Parkinson's Disease (PD) trials